Literature DB >> 1296709

Detection of single-base mutations in a mixed population of cells: a comparison of SSCP and direct sequencing.

T A Smith1, J Whelan, P J Parry.   

Abstract

Single-base-pair changes in several genes have been shown to be important in carcinogenesis. We have compared the sensitivity of two commonly used techniques for detection of single-base-pair changes. Defined populations of cells were prepared by mixing wild-type Chinese hamster ovary cells with cells carrying a known mutation in the CTP synthetase gene. RNA was extracted and analyzed for the mutation by single-strand conformational polymorphism and direct sequence analysis of polymerase chain reaction products. We found that both techniques were able to detect the mutation when it was present in 25% of the cells, but that direct sequencing was slightly more sensitive and able to detect the mutation when it was present in only 20% of the population.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1296709     DOI: 10.1016/1050-3862(92)90039-8

Source DB:  PubMed          Journal:  Genet Anal Tech Appl        ISSN: 1050-3862


  4 in total

1.  Fluorescence-based mutation detection. Single-strand conformation polymorphism analysis (F-SSCP).

Authors:  J S Ellison
Journal:  Mol Biotechnol       Date:  1996-02       Impact factor: 2.695

Review 2.  JAK2 V617F in myeloid disorders: molecular diagnostic techniques and their clinical utility: a paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology.

Authors:  David P Steensma
Journal:  J Mol Diagn       Date:  2006-09       Impact factor: 5.568

3.  A comparison of two methods for screening CEBPA mutations in patients with acute myeloid leukemia.

Authors:  Jeung-Yeal Ahn; Katie Seo; Olga Weinberg; Scott D Boyd; Daniel A Arber
Journal:  J Mol Diagn       Date:  2009-06-12       Impact factor: 5.568

4.  p53 mutations as a marker of malignancy in bladder washing samples from patients with bladder cancer.

Authors:  H A Phillips; G C Howard; W R Miller
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.